Navigation Links
Mindray Announces 2012 Fourth Quarter and Full Year Results
Date:2/25/2013

MEDICAL INTERNATIONAL LIMITEDCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(Dollars in thousands)Three months ended December 31,Year ended December 31,2011201220112012 US$  US$  US$  US$  (unaudited)  (unaudited) (Note 1) (unaudited) Cash flow from operating activities:  Net income

46,79555,849166,629180,209  Adjustments to reconcile net income to net cash from operating activities

13,35321,09149,82571,797  Changes in current assets and liabilities

36,28767,953(24,050)73,660Net cash generated from operating activities96,435144,893192,404325,666Cash flow from investing activities:Acquisition cost, net of cash acquired

-(3,064)(6,530)(34,552)Capital expenditure

(26,207)(18,361)(89,938)(65,605)Increase in restricted cash and restricted investment

-(21,528)-(21,528)Proceeds from sale of short-term investments

7,150-100,274144,395Increase in short-term investments and changes in other investing activities

(70,940)(19,727)(262,085)(255,255)Net cash used in investing activities(89,997)(62,680)(258,279)(232,545)Cash flow from financing activities:Repayment of bank loans

-(2,475)-(2,475)Proceeds from bank loans

--85,39952,000Dividend paid

--(34,522)(46,401)Proceeds from exercise of options

1,7301,9647,12124,593Stock repurchase

(10,160)-(10,160)-Cash contribution from non-controlling interest

--797506Net cash (used in) generated from financing activities(8,430)(511)48,63528,223Net (decrease) increase in cash and cash equivalents(1,992)81,702(17,240)121,344Cash and cash equivalents at beginning of period

124,785164,499137,502124,311Effect of exchange rate changes on cash

1,5181,6584,0492,204Cash and cash equivalents at end of period124,311247,859124,311247,859(1) Financial information is extracted from the audited financial statements included in the Company's fisca
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Mindray Files Annual Report on Form 20-F with the U.S. Securities and Exchange Commission
2. Mindray Medical to Acquire Controlling Stake in Hangzhou Optcla Medical Instrument
3. Mindray Announces First Quarter 2012 Financial Results
4. Mindray Medical to Present at AACC Clinical Lab Expo 2012
5. Mindray Medical Completes Acquisition of Dragonbios Orthopedics Business
6. Mindray to Report Second Quarter 2012 Financial Results on August 6, 2012
7. Mindray Announces Second Quarter 2012 Financial Results
8. Mindray Medical to Participate in MEDICA 2012 in Dusseldorf, Germany
9. Mindray Medical Announces Top Management Change
10. Mindray DS USA, Inc. has Initiated a Voluntary Recall Affecting the A3/A5 Anesthesia Delivery System
11. Mindray to Showcase Enhancements to DC-8 Ultrasound System at RSNA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... MOUNT PROSPECT, Ill. , May 21, 2013 /PRNewswire-USNewswire/ ... Domain (gTLD) approval process, the National Association of Boards ... own and operate the .PHARMACY domain suffix has passed ... initial evaluation. NABP intends to launch the .PHARMACY gTLD ... new domain available to legitimate online pharmacies and related ...
(Date:5/21/2013)... Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: ... solution provider and operator of the largest network of ... parent of Chang,an Hospital, today reported its unaudited consolidated ... 2013 [1] . First Quarter 2013 Highlights ... revenues generated from the network business and hospital business, ...
(Date:5/21/2013)... , May 21, 2013  NxStage Medical, Inc. (Nasdaq: ... dialysis products, today announced that it has entered into ... and in-center products to DaVita, the kidney care division ... ) For the use of products ... , NxStage has executed a second amended and ...
Breaking Medicine Technology:NABP's .PHARMACY Proposal Passes Initial ICANN Evaluation 2NABP's .PHARMACY Proposal Passes Initial ICANN Evaluation 3Concord Medical Reports First Quarter 2013 Financial Results 2Concord Medical Reports First Quarter 2013 Financial Results 3Concord Medical Reports First Quarter 2013 Financial Results 4Concord Medical Reports First Quarter 2013 Financial Results 5Concord Medical Reports First Quarter 2013 Financial Results 6Concord Medical Reports First Quarter 2013 Financial Results 7Concord Medical Reports First Quarter 2013 Financial Results 8Concord Medical Reports First Quarter 2013 Financial Results 9Concord Medical Reports First Quarter 2013 Financial Results 10Concord Medical Reports First Quarter 2013 Financial Results 11Concord Medical Reports First Quarter 2013 Financial Results 12Concord Medical Reports First Quarter 2013 Financial Results 13NxStage Announces New Agreements with DaVita 2
... 2012  Islet Sciences, Inc., (OTCBB: ISLT) a biotechnology company ... technologies in the field of transplantation therapy for patients ... technology from Yale University. "In the ... Herold and his colleagues at Yale University School of ...
... /PRNewswire-iReach/ -- PharmacyGPO, Inc.,  a ... the United States, today announced a three-year agreement ... (Photo: http://photos.prnewswire.com/prnh/20120507/CG01217 ) ... Smith, a leading national wholesaler, will be the ...
Cached Medicine Technology:Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic 2PharmacyGPO Buying Group Selects H. D. Smith as Primary National Distributor 2PharmacyGPO Buying Group Selects H. D. Smith as Primary National Distributor 3
(Date:5/21/2013)... results from SOURCE XT one of the largest, ... reported today at EuroPCR 2013 show good clinical outcomes ... success for all access approaches, valve sizes and delivery ... 2688 consecutively enrolled patients (mean age 81.5 years) undergoing ... centres in 17 countries between July 2010 and October ...
(Date:5/21/2013)... 2013, Paris, France: The Orsiro stent, which is ... biodegradable polymer, demonstrated non-inferiority to the Xience Prime ... in-stent late lumen loss at nine months in ... EuroPCR 2013 today. , The BIOFLOW-II substudy used ... to quantitatively assess neointimal hyperplasia and stent apposition ...
(Date:5/21/2013)... 21, 2013 Arizona State University ... want to develop their ideas into solutions, products ... , The university is recruiting participants for AREA48 ... space” that provides early-stage entrepreneurs with opportunities to ... open to anyone, ASU is particularly seeking participation ...
(Date:5/21/2013)... 21, 2013 According to a May 13, ... Use of Botox,” Botox injections have become the ... in 2002 (Go to goo.gl/8iYbD). Although it is mostly associated ... men. The injection makes facial wrinkles less visible by paralyzing ... for about three months. This means that people who are ...
(Date:5/21/2013)... York, New York (PRWEB) May 21, 2013 ... Wright Conserve hip replacement lawsuits in ... an Order in response to a request from Plaintiffs’ ... of the Defendant. The May 17th Order grants ... interviews may be conducted. (In re: Wright Medical Technology, ...
Breaking Medicine News(10 mins):Health News:Biodegradable stent proves non-inferior to drug-eluting stent 2Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 2Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 3Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 4Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 2Health News:Wright Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Wright Conserve Hip Replacement Litigation 3
... guinea worm disease is almost eradicated from the planet earth. ... could be exterminated in a couple of years from now. ... ,Currently around 25,000 people in nine countries across the ... million people in twenty countries in the early 1980s. ...
... performance is reported to be the latest trend which is ... keen to learn and develop their skills to make sure ... interest of patients. ,More than 170 physician ... emergency care through the Physician Consortium for Performance Improvement organized ...
... cancers of the “triple negative” type are destructive and lethal, ... to a novel// study Published in the May 1, 2007 ... these tumors occur commonly among women who are African American ... the lower socioeconomic status (SES). The study also showed that ...
... children suffering ADHD are prone to alcohol addiction in ... suggesting that alcohol related problems could begin around the ... family stress appear to add to the risk of ... that children with attention deficit hyperactivity disorder (ADHD) are ...
... the incidence of chicken pox cases is on the rise. ... especially in the southern districts, are gearing up to tackle ... would be the first casualty if chicken pox is not ... cases have been already reported in a rather serious condition ...
... Going in for angioplasty? Pause for a moment. It has now ... arteries//. ,So much so, more than half a ... or premature angioplasty, suggests a new study. ,More important, ... heart patients, it says. ,Dr William Boden of ...
Cached Medicine News:Health News:'Triple Negative' Breast Cancers Seem to Affect the Young, Minority 2Health News:ADHD Problem in Children – a Risk Factor for Alcohol Problems in Later Lif 2Health News:ADHD Problem in Children – a Risk Factor for Alcohol Problems in Later Lif 3
Alphabetically organized monographs on more than 1,000 generic and 3,000 trade name drugs....
... Drug Companion is a comprehensive, authoritative ... 5,500 entries, with overdose management, Canadian ... This "Mini-Suite" of drug references and ... the PEPID Suites (ED, PRIMARY CARE ...
... Pocket Drug Guide 2005 includes over 1,000 ... relating to their selection and administration. Organized ... drug includes key data featuring common uses ... implications and patient education information. A list ...
... A to Z Drug Facts ... detailed information on thousands of medications. ... contraindications, side effect, drug interactions, patient ... ideal drug reference for physicians, students, ...
Medicine Products: